Slice of Healthcare

👟 A walk through downtown St. Pete… and a deep dive into the future of pharmacy benefits. I caught up with Jordan Counts, Director of Pharmacy Services at Quantum Health, to talk GLP-1s, specialty drugs, and how employers can navigate the rising tide of cost and complexity. We covered: • Why GLP-1s are driving up costs — fast • The biggest challenges employers face right now • How navigation platforms fit into the evolving PBM landscape • What makes Quantum’s weight management approach stand out Jordan broke it down with clarity and zero fluff in 90 seconds. If you care about pharmacy strategy, cost containment, or member outcomes, you’ll want to hear this. Watch our walk & talk — quick clips, big insights. 👇 What’s your take: 𝗔𝗿𝗲 𝗚𝗟𝗣-𝟭𝘀 𝗮 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵—𝗼𝗿 𝗮 𝗯𝘂𝗱𝗴𝗲𝘁 𝗯𝗿𝗲𝗮𝗸𝗲𝗿? (𝗰𝗼𝗺𝗺𝗲𝗻𝘁 𝗯𝗲𝗹𝗼𝘄) #GLP1 #PharmacyStrategy #SoHCInsights

OVERJET Launches Dental Clarity Network to Improve Patient Experience Learn more & get our take 👇 https://lnkd.in/gPNCUEKA “We’re thrilled to partner with innovators who want to move the dental industry forward on insurance reimbursement and eliminate a key pain point for everyone. Cross-industry problems require cross-industry solutions.” — Wardah Inam, CEO at Overjet “We’re focused on ensuring patients have access to the dental care needed to support their well-being, without the concern of receiving a surprise bill.” — Peter Fuentes, DMD, Chief Dental Officer at MetLife “Patients deserve to have confidence in their insurance benefits coverage when they move forward with dental care. Ultimately, ReviewPASS will allow us to give patients clarity on their costs upfront.” — Andrew Mintz, CEO at The Smilist Management #SoHCNews

DispatchHealth and Medically Home Announce Merger to Expand High-Acuity Home Care Learn more & get our take 👇 https://lnkd.in/dNFhqUMK “This merger unlocks a future where high-acuity care at home is the new standard.” — Mark Prather MD, MBA, Co-founder & Executive Chair at DispatchHealth “This merger brings together two complementary pioneers in hospital-level care at home, accelerating our ability to expand access, lower costs, and improve capacity for health systems.” — Jennifer Webster, CEO at DispatchHealth “For many patients, the best hospital bed is the one at home.” — Graham Barnes, CEO at Medically Home #SoHCNews

Pramana and ARUP Laboratories Partner to Advance AI in Hematopathology Learn more & get our take 👇 https://lnkd.in/gJyv5htN “Hematopathology involves highly complex and difficult-to-scan specimens, where traditional methods often fall short in delivering consistent and reproducible results. By combining our deep clinical expertise with Pramana’s large-scale digitization and AI-driven analysis, we have the ability to develop and clinically validate new AI algorithms that will improve diagnostic accuracy and workflow efficiency.” — David Ng, MD, FCAP, Medical Director, Hematologic Flow Cytometry and Applied AI at ARUP Laboratories “This collaboration with ARUP Laboratories showcases how AI-driven pathology can redefine industry standards, making diagnostics more scalable, efficient, and interoperable. By leveraging edge computing, we’re accelerating the adoption of advanced diagnostic algorithms, including those for complex hematopathology cases.” — Prasanth Perugupalli, Chief Product Officer at Pramana #SoHCNews

Strive Health & Zing Health Expand Kidney Care Partnership Learn more & get our take 👇 https://lnkd.in/g5xKvZpD “Our collaboration with Zing has strengthened our shared commitment to delivering high-quality, coordinated care to individuals living with kidney disease. Together, Strive’s value-based care model and Zing’s benefit plans proactively address the clinical challenges and social determinants of health that impact patient outcomes and create a more unified care experience.” — Chris Riopelle, Co-Founder & CEO at Strive Health “Our collaboration with Strive represents the future of Medicare Advantage, where members receive holistic, coordinated care from providers who understand their unique health needs. This partnership is a testament to our commitment to improving outcomes for those managing kidney disease.” — Andrew Clifton, CEO at Zing Health #SoHCNews

Greenspace Health Secures Series B Investment from ABS Capital Learn more & get our take 👇 https://lnkd.in/g_6fC4Da “Measurement-Based Care is no longer optional—it is essential to ensure individuals have access to care that leads to meaningful improvement. With ABS Capital’s investment, we are advancing the next generation of MBC technology to support providers in delivering the highest standard of care.” — Jeremy Weisz, CEO & Co-Founder at Greenspace Health “The need for real-time data and insights has never been greater. Greenspace is uniquely positioned to transform care delivery, improve clinical outcomes, and enable value-based models. We’re excited to support their continued growth and impact.” — Cal Wheaton, Partner at ABS Capital “The behavioral health industry has historically lacked the data needed for continuous innovation. As value-based care becomes a standard, Measurement-Based Care is the foundation for improving quality, demonstrating impact, and accessing new care models.” — Simon Weisz, President & Co-Founder at Greenspace Health #SoHCNews

Flagship Pioneering Unveils Lila Sciences to Pioneer Scientific Superintelligence Learn more & get our take 👇 https://lnkd.in/gBBs_eqM “Lila’s mission to responsibly achieve Scientific Superintelligence is born out of the belief that this is the most important opportunity of our time.” — Geoffrey von Maltzahn, Ph.D., Co-Founder & CEO at Lila Sciences “Lila represents an ambitious undertaking that we believe will accelerate science with enormous benefit to society.” — Noubar Afeyan, Ph.D., Founder & CEO at Flagship Pioneering “The next frontier in scientific discovery will come from enabling AI to design and run experiments at unprecedented scale.” — Molly Gibson, Ph.D., Co-Founder & President, Future Science at Lila Sciences #SoHCNews

Advarra Launches Oncology Research Pulse to Advance Cancer Trials Learn more & get our take 👇 https://lnkd.in/gBd-Nzz3 “Cancer research is evolving at an unprecedented pace. New therapies, shifting regulations, and cutting-edge technologies are transforming how trials are designed and conducted. Yet, persistent challenges remain—study startup is too slow, research sites are overburdened, and too many patients struggle to access innovative treatments.” – Christine Senn, PhD, Senior Vice President and Head of Site-Sponsor Innovation at Advarra “Collaboration is essential in overcoming the complexities of modern oncology research. Programs such as Oncology Research Pulse provide a valuable forum for key stakeholders to come together, share insights, and work toward practical solutions that improve trial efficiency and patient access.” – Walter Stadler, MD, FACP, Chief Clinical Officer, City of Hope at Chicago #SoHCNews

Sunbird Bio Appoints Vijay Parthasarathy, PhD, MBA as Chief Product and Strategy Officer Learn more & get our take 👇 https://lnkd.in/g7kdhS7y “We are thrilled to continue growing our team with the addition of Dr. Parthasarathy, an accomplished industry leader with a history of bringing innovative scientific advancements to market. His track record of successfully developing and commercializing diagnostics in multiple disease areas will be a tremendous asset to our team, accelerating the impact that our technology could have on patients with neurological disorders.” — John McDonough, Executive Chairman & CEO at Sunbird Bio “Sunbird Bio is a rapidly expanding company pioneering a first-of-its-kind, much-needed diagnostic platform for neurodegenerative diseases – an innovation that inspired me to join the team. This technology has real potential to meaningfully improve the lives of patients suffering from devastating neurodegenerative diseases, and I am excited to help bring it to those who need it most.” — Vijay Parthasarathy, Ph.D., MBA, Chief Product and Strategy Officer at Sunbird Bio #SoHCNews

Many healthcare providers believe they’re delivering great care—until they see the data. Find out how real-time insights are helping teams improve hypertension management in episode 488. Guests: LuAnn Kimker, SVP of Clinical Innovation at Azara Healthcare & Sinead Forkan-Kelly MHA, RN, FACHE, Director of Client Success & Growth Strategies at the American Medical Association. 🔗 https://lnkd.in/gTNJFb3S #healthcare #data #SoHCPodcasts